Press Releases :: Aurinia Pharmaceuticals Inc. (AUPH)

May 9, 2019 • 4:05 pm EDT

Aurinia Pharmaceuticals to Release First Quarter 2019 Financial Results on May 14, 2019

April 30, 2019 • 6:05 am EDT

Aurinia Further Strengthens Its Board of Directors with the Appointment of Dr. Daniel Billen

April 24, 2019 • 4:05 pm EDT

Aurinia Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

April 11, 2019 • 4:30 pm EDT

Aurinia Announces Appointment of Peter Greenleaf as Chief Executive Officer and Board Director and the Elevation of Dr. George M. Milne, Jr. to Chairman of the Board

March 19, 2019 • 4:02 pm EDT

Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights

March 14, 2019 • 7:00 am EDT

Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease

March 7, 2019 • 4:05 pm EST

Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2018 Financial Results on March 19, 2019

February 27, 2019 • 6:30 am EST

Aurinia Closes At-The-Market Facility

February 25, 2019 • 7:00 am EST

Aurinia Receives Notice of Allowance from the US Patent and Trademark Office for Claims Directed to Its Novel Voclosporin Dosing Protocol for Lupus Nephritis

February 20, 2019 • 4:01 pm EST

Aurinia to Present at the 8th Annual SVB Leerink Global Healthcare Conference New York City

Select a page:

rss_feed News RSS

©2025 Aurinia Pharmaceuticals Inc. All Rights Reserved. US-LUP-2300105 08/23